Literature DB >> 9177263

In vitro transcriptional activation of p21 promoter by p53.

T K Kim1.   

Abstract

The tumor suppressor p53 can control cell growth by inducing cell cycle arrest. This is effected, at least in part, by transcriptional activation of p21 gene, a cell cycle inhibitor. Here in vitro transcription assay for p21 has been established. The assay recapitulates activation of p21 promoter mediated by p53 in vitro. Thus this in vitro assay will allow to study how transcriptional regulation of p21 can be linked to cell cycle controls during development and neoplastic transformation processes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177263     DOI: 10.1006/bbrc.1997.6637

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Transcriptional inhibition of p21WAF1/CIP1 gene (CDKN1) expression by survivin is at least partially p53-dependent: evidence for survivin acting as a transcription factor or co-factor.

Authors:  Lei Tang; Xiang Ling; Wensheng Liu; Gokul M Das; Fengzhi Li
Journal:  Biochem Biophys Res Commun       Date:  2012-04-06       Impact factor: 3.575

Review 2.  The individualization of cancer therapy: the unexpected role of p53.

Authors:  William N Hait; Jin-Ming Yang
Journal:  Trans Am Clin Climatol Assoc       Date:  2006

3.  Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells.

Authors:  B Wen; E Deutsch; E Marangoni; V Frascona; L Maggiorella; B Abdulkarim; N Chavaudra; J Bourhis
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

4.  Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.

Authors:  Véronique Ouellet; Tak Hay Ling; Karine Normandin; Jason Madore; Christian Lussier; Véronique Barrès; Dimcho Bachvarov; Claudine Rancourt; Patricia N Tonin; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  BMC Cancer       Date:  2008-11-26       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.